Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Accumulated Depreciation (2020 - 2025)

Maxcyte (MXCT) has disclosed Accumulated Depreciation for 6 consecutive years, with $17.3 million as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation rose 27.02% to $17.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.3 million through Dec 2025, up 27.02% year-over-year, with the annual reading at $17.3 million for FY2025, 27.02% up from the prior year.
  • Accumulated Depreciation for Q4 2025 was $17.3 million at Maxcyte, up from $17.0 million in the prior quarter.
  • The five-year high for Accumulated Depreciation was $17.3 million in Q4 2025, with the low at $3.6 million in Q2 2021.
  • Average Accumulated Depreciation over 5 years is $9.7 million, with a median of $9.3 million recorded in 2023.
  • The sharpest move saw Accumulated Depreciation skyrocketed 65.6% in 2023, then increased 27.02% in 2025.
  • Over 5 years, Accumulated Depreciation stood at $4.4 million in 2021, then soared by 43.51% to $6.3 million in 2022, then surged by 63.92% to $10.3 million in 2023, then skyrocketed by 32.14% to $13.6 million in 2024, then increased by 27.02% to $17.3 million in 2025.
  • According to Business Quant data, Accumulated Depreciation over the past three periods came in at $17.3 million, $17.0 million, and $16.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.